biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a2p5-01a-11d-a19y-09
biospecimen_aliquot__bcr_aliquot_uuid	34e624a6-5da3-4150-bfb8-d86ee8732d08
biospecimen_aliquot__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a2p5-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0118968236
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-11-30
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	5
biospecimen_aliquot__plate_id	a19y
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a2p5-01a-11d
biospecimen_analyte__bcr_analyte_uuid	f2708e4c-65a7-43c1-9710-9f312201466a
biospecimen_analyte__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a2p5-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a2p5
biospecimen_diagnostic_slides__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a2p5-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	375b5e5d-d8d0-425c-9163-6df26e31bbe1
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a2p5
biospecimen_normal_control__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
biospecimen_normal_control__ncedna_dna_conc	0.193
biospecimen_normal_control__ncedna_dna_qm	picogreen
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	103.6
biospecimen_portion__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
biospecimen_portion__bcr_portion_barcode	tcga-e2-a2p5-01a-11
biospecimen_portion__bcr_portion_uuid	d268d7c7-c3d2-4859-8a5f-09668eaf5586
biospecimen_portion__bcr_sample_barcode	tcga-e2-a2p5-01a
biospecimen_portion__date_of_creation	2011-08-26
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a2p5-01a-11d
biospecimen_protocol__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a2p5-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
biospecimen_sample__bcr_sample_barcode	tcga-e2-a2p5-01a
biospecimen_sample__bcr_sample_uuid	cd8ac496-cd1b-426f-8e17-8f15ba8e94d1
biospecimen_sample__days_to_collection	219
biospecimen_sample__initial_weight	260
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-e2-a2p5.85e91c9f-9f61-4a25-b4d9-1bcbc7108f5e.pdf
biospecimen_sample__pathology_report_uuid	85e91c9f-9f61-4a25-b4d9-1bcbc7108f5e
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a2p5-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	b4da5ffb-397d-4760-8e01-a67791dd37fc
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a24a
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a2p5-01a-21-a24a-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	14
biospecimen_shipment_portion__shipment_portion_month_of_shipment	11
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
biospecimen_slide__bcr_sample_barcode	tcga-e2-a2p5-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a2p5-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	881a6b1b-6825-4d7a-828c-d4a0fcc5bae1
biospecimen_slide__image_file_name	tcga-e2-a2p5-01a-01-ts1.881a6b1b-6825-4d7a-828c-d4a0fcc5bae1.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	2
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	40
biospecimen_slide__percent_tumor_cells	60
biospecimen_slide__percent_tumor_nuclei	85
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a2p5
biospecimen_tumor_sample__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
clinical_drug__bcr_drug_barcode	tcga-e2-a2p5-d33517
clinical_drug__bcr_drug_uuid	bb98f3fd-3e77-42de-b60f-4556f6bbdbef
clinical_drug__bcr_patient_barcode	tcga-e2-a2p5
clinical_drug__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
clinical_drug__form_completion_date	2012-7-5
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	163
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-e2-a2p5-f68575
clinical_follow_up__bcr_followup_uuid	76f6e0c5-bd3f-4008-aa91-1e51f54af7df
clinical_follow_up__bcr_patient_barcode	tcga-e2-a2p5
clinical_follow_up__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
clinical_follow_up__death_days_to	821
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2014-11-26
clinical_follow_up__new_tumor_event_dx_days_to	597
clinical_follow_up__new_tumor_event_dx_indicator	yes
clinical_follow_up__new_tumor_event_pharmaceutical_tx	yes
clinical_follow_up__new_tumor_event_radiation_tx	no
clinical_follow_up__new_tumor_event_site	bone
clinical_follow_up__new_tumor_event_surgery	no
clinical_follow_up__new_tumor_event_type	distant metastasis
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	with tumor
clinical_follow_up__vital_status	dead
clinical_omf__bcr_omf_barcode	tcga-e2-a2p5-o17328
clinical_omf__bcr_omf_uuid	88a1ea87-49d6-4fb2-89cf-759d1f182a05
clinical_omf__bcr_patient_barcode	tcga-e2-a2p5
clinical_omf__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
clinical_omf__days_to_surgical_resection	46
clinical_omf__drug_tx_indicator	no
clinical_omf__form_completion_date	2011-10-10
clinical_omf__malignancy_type	synchronous malignancy
clinical_omf__other_malignancy_anatomic_site	breast
clinical_omf__other_malignancy_histological_type	other, specify
clinical_omf__other_malignancy_histological_type_text	ductal carcinoma in situ
clinical_omf__other_malignancy_laterality	right
clinical_omf__radiation_tx_indicator	no
clinical_omf__system_version	7th
clinical_patient__age_at_diagnosis	78
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n3
clinical_patient__ajcc_pathologic_tumor_stage	stage iiic
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-e2-a2p5
clinical_patient__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
clinical_patient__birth_days_to	-28621
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	allred score = 8
clinical_patient__er_positivity_scale_other	allred score = 8
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-12-19
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.0
clinical_patient__her2_fish_status	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	yes
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	326
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	25
clinical_patient__lymph_nodes_examined_he_count	21
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a2p5
clinical_patient__pr_positivity_define_method	allred score = 8
clinical_patient__pr_positivity_scale_other	allred score = 8
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	black or african american
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e2-a2p5
clinical_radiation__bcr_patient_uuid	f0de67ff-8967-4fce-9c12-0e07193285cd
clinical_radiation__bcr_radiation_barcode	tcga-e2-a2p5-r33529
clinical_radiation__bcr_radiation_uuid	9d9deece-7130-4b3b-890a-ccbd6a3a989f
clinical_radiation__form_completion_date	2012-7-5
clinical_radiation__radiation_adjuvant_fractions_total	28
clinical_radiation__radiation_adjuvant_units	gy
clinical_radiation__radiation_therapy_ended_days_to	143
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	regional site
clinical_radiation__radiation_therapy_started_days_to	98
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	60.4
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A2P5-01A-11D-A19Y-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A2P5-01A-11D-A19Y-09.bed.meta
manually_curated__id	tcga-e2-a2p5-01a-11d-a19y-09
manually_curated__md5sum	9a957ec1d0f889cc2c6f6e50dc9aa48c
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	34e624a6-5da3-4150-bfb8-d86ee8732d08
manually_curated__tumor_tag	brca
